Cancer Treatment News and Research

RSS

Van Andel Research Institute commits $7.5M to support epigenetic therapy in cancer treatment

The work of one of the Stand Up To Cancer (SU2C) inaugural Dream Teams, launched in 2009 to focus on epigenetic therapy in cancer treatment, will continue with the commitment of $7.5 million from Van Andel Research Institute (VARI).

20 Oct 2014

NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

Indianapolis interventional medical device maker NICO Corporation and Toronto-based 3D visualization leader Synaptive Medical announced today at the Congress of Neurological Surgeons Annual Meeting that they have joined forces to integrate their innovative technologies for brain surgery.

20 Oct 2014

Genetic changes in blood cells of older people linked to lymphoma, leukemia

At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis.

20 Oct 2014

Anti-cancer nanomedicines with smaller sizes exhibit enhanced performance in vivo, show studies

Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy.

17 Oct 2014

Statistical analysis shows stage of breast cancer predicts treatment choice

Why did 43 percent of South Dakota women diagnosed with early-stage breast cancer surveyed choose mastectomy rather than lumpectomy?

17 Oct 2014

New automaton model simulates various scenarios of tumor growth

Cancer constantly wages war on the human body. Battles are won, lost or sometimes end in a stalemate. In pancreatic cancer, this stalemate—known as tumor dormancy—can last up to 25 years before becoming aggressively malignant, a phenomena that is poorly understood.

17 Oct 2014

California agency issues 'report cards' on insurers, medical groups

The California Office of the Patient Advocate Wednesday released the report cards, which are based on 2013 claims data and patient surveys, a month ahead of Covered California's 2015 open enrollment period.

16 Oct 2014

Study: Nursing home care quality not associated with risk of hospital readmission or death

Nursing home care quality does not impact the likelihood of patients being readmitted to the hospital or dying within 30 days of discharge from hospital to nursing home, according to a new analysis of Medicare data and nursing home performance measures by Penn Medicine researchers.

16 Oct 2014

Scientists combine new type of nanoparticle with photodynamic therapy to kill cancer cells

An international group of scientists led by Gang Han, PhD, at the University of Massachusetts Medical School, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set cancer cells in vivo with minimal damage to surrounding tissue and fewer side effects than chemotherapy. This promising new treatment strategy could expand the current use of photodynamic therapies to access deep-set cancer tumors.

16 Oct 2014

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

13 Oct 2014

Pharmaceutical industry withdraws from the antibiotic space

The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive.

13 Oct 2014

Champalimaud Foundation to establish cancer institute in Rajasthan, India

The Lisbon based Champalimaud Foundation has entered into a partnership with the Government of Rajasthan, India, to establish a state-of-the–art cancer institute with world-class facilities.

12 Oct 2014

Recent clinical study sheds light on potential approach to more personalized care for pancreatic cancer

Pancreatic cancer is one of the deadliest cancers. Even with aggressive treatment, the prognosis is poor, with various factors stacking the odds against successful treatment: early detection is uncommon, it tends to spread quickly and recurrence is likely. However, several newer approaches show promise in increasing the response rate to pancreatic cancer treatment.

10 Oct 2014

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors.

9 Oct 2014

Tel Aviv University researcher advances novel strategy to fight cancer by shoring up the immune system

Two years ago, Prof. Eshel Ben-Jacob of Tel Aviv University's School of Physics and Astronomy and Rice University's Center for Theoretical Biological Physics made the startling discovery that cancer, like an enemy hacker in cyberspace, targets the body's communication network to inflict widespread damage on the entire system.

8 Oct 2014

'Achilles heel' in metabolic pathway could stop growth of lung cancer cells

Researchers at UT Southwestern Medical Center have found an "Achilles heel" in a metabolic pathway crucial to stopping the growth of lung cancer cells.

8 Oct 2014

Avidity NanoMedicines closes $6M convertible note financing, expands investor syndicate

Avidity NanoMedicines today announced that it has expanded its investor syndicate through the closing of a $6 million convertible note financing co-led by Fidelity Biosciences and TPG Biotech.

7 Oct 2014

UNM Cancer Center surgeon receives NCI's Cancer Clinical Investigator Team Leadership Award

Surgeon Teresa Rutledge, MD, recently received the National Cancer Institute's Cancer Clinical Investigator Team Leadership Award. Only 11 people nationwide received the award this year. Dr. Rutledge is the third faculty member in the history of the University of New Mexico Cancer Center to be recognized with this honor.

7 Oct 2014

Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.

6 Oct 2014

Scientists shed new light on how LAMR1 and Gal-3 proteins can cause meningitis, septicaemia

Previously undiscovered secrets of how human cells interact with a bacterium which causes a serious human disease have been revealed in new research by microbiologists at The University of Nottingham.

5 Oct 2014

Cancer Treatment News and Research

Van Andel Research Institute commits $7.5M to support epigenetic therapy in cancer treatment

NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

Genetic changes in blood cells of older people linked to lymphoma, leukemia

Anti-cancer nanomedicines with smaller sizes exhibit enhanced performance in vivo, show studies

Statistical analysis shows stage of breast cancer predicts treatment choice

New automaton model simulates various scenarios of tumor growth

California agency issues 'report cards' on insurers, medical groups

Study: Nursing home care quality not associated with risk of hospital readmission or death

Scientists combine new type of nanoparticle with photodynamic therapy to kill cancer cells

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Pharmaceutical industry withdraws from the antibiotic space

Champalimaud Foundation to establish cancer institute in Rajasthan, India

Recent clinical study sheds light on potential approach to more personalized care for pancreatic cancer

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

Tel Aviv University researcher advances novel strategy to fight cancer by shoring up the immune system

'Achilles heel' in metabolic pathway could stop growth of lung cancer cells

Avidity NanoMedicines closes $6M convertible note financing, expands investor syndicate

UNM Cancer Center surgeon receives NCI's Cancer Clinical Investigator Team Leadership Award

Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Scientists shed new light on how LAMR1 and Gal-3 proteins can cause meningitis, septicaemia

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News